Document:

Form of Tender and Support Agreement

 Exhibit 10.1 
 FORM OF TENDER AND SUPPORT AGREEMENT 
 This TENDER AND SUPPORT AGREEMENT, dated as of May 21,
2009 (this “Agreement”), is by and among [Alan H. Auerbach, Arie S. Belldegrun, or Horizon BioMedical Ventures, LLC, a Delaware limited liability company] (“Stockholder”), Johnson & Johnson, a New Jersey
corporation (“Parent”), and Kite Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Purchaser”). Capitalized terms used but not defined herein have the meanings assigned to them in
the Agreement and Plan of Merger, dated as of the date of this Agreement (together with any amendments or supplements thereto, the “Merger Agreement”), by and among Parent, Purchaser and Cougar Biotechnology, Inc., a Delaware
corporation (the “Company”). 
 RECITALS 
 WHEREAS, Stockholder beneficially owns (i) the shares of common stock of the Company, par value $0.0001 per share (“Common Stock”),
set forth on Schedule A (the “Schedule A Shares”) and/or (ii) the warrants to purchase shares of Common Stock, set forth on Schedule A (the “Schedule A Warrants”); 
 WHEREAS, concurrently with the execution and delivery of this Agreement, Parent, Purchaser and the Company are entering into the Merger Agreement, which
provides for, among other things, the making of a tender offer (such offer, as it may be amended from time to time as permitted by the Merger Agreement, the “Offer”) by Purchaser to purchase all of the issued and outstanding shares
of Common Stock at a price of $43.00 per Share (such amount or any higher amount per Share that may be paid pursuant to the Offer being hereafter referred to as the “Offer Price”); 
 WHEREAS, following the Acceptance Time and upon the terms and subject to the conditions set forth in the Merger Agreement, Purchaser will be merged with
and into the Company with the Company as the surviving corporation (the “Merger”), in accordance with the General Corporation Law of the State of Delaware, whereby each issued and outstanding share of Common Stock not owned directly
or indirectly by Parent, Purchaser or the Company (other than Dissenting Shares) will be converted into the right to receive the Merger Consideration in cash, without interest and subject to any applicable withholding taxes; and 
 WHEREAS, as an inducement to and condition to Parent’s and Purchaser’s willingness to enter into the Merger Agreement, Parent and Purchaser
have required that Stockholder enter into this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual covenants,
representations, warranties and agreements set forth herein, and intending to be legally bound, the parties agree as follows: 
 Section 1.
Certain Definitions. The following capitalized terms, as used in this Agreement, shall have the meanings set forth below: 
 “Agreement Period” means the period beginning on the date of this Agreement and 

 
ending on the Termination Time. 
 “beneficial ownership” of any security by any Person means “beneficial ownership” of such security as determined pursuant to Rule 13d-3 under the Exchange Act, including all securities as to which such
Person has the right to acquire, without regard to the 60-day period set forth in such rule. The terms “beneficially owned” and “beneficial owner” shall have correlative meanings. 
 “Permitted Transferee” means, with respect to any Stockholder, (i) a spouse, lineal descendant or antecedent, brother or sister,
adopted child or grandchild or the spouse of any child, adopted child, grandchild or adopted grandchild of Stockholder, (ii) any charitable organization described in Section 170(c) of the Code, (iii) any trust, the beneficiaries of
which include only the Persons named in clause (i) or (ii), (iv) any corporation, limited liability company or partnership, the stockholders, members and general or limited partners of which include only the Persons named in
clause (i) or (ii), or (v) if Stockholder is a partnership or limited liability company, one or more partners or members of Stockholder or an affiliated corporation under common control with Stockholder. 
 “Shares” means (i) Stockholder’s Schedule A Shares and (ii) all shares of Common Stock of which Stockholder acquires
beneficial ownership during the Agreement Period, including any shares of Common Stock acquired by means of purchase, dividend or distribution, or issued upon the exercise of any warrants or options, or the conversion of any convertible securities
or otherwise. 
 “Warrants” means (i) Stockholder’s Schedule A Warrants and (ii) all warrants of which
Stockholder acquires beneficial ownership during the Agreement Period, which warrants are convertible into, or exchangeable or exercisable for, shares of Common Stock from the Company. 
 Section 2. Agreement to Tender; Exercise of Warrants. 
 (a) Agreement to Tender. 
 (i)
Unless this Agreement shall have been terminated in accordance with Section 13(d), Stockholder shall (i) validly tender or cause to be tendered in the Offer all of Stockholder’s Shares (excluding for purposes of this
Section 2(a) any of Stockholder’s Shares that are the subject of unexercised options to purchase Common Stock granted or awarded under any of the Company’s stock plans or unexercised Warrants) pursuant to and in accordance with
the terms of the Offer (including the tender of all certificates, documents or instruments required to be delivered pursuant to the terms of the Offer), as promptly as practicable (but no later than the close of business on the tenth (10th) business day) following the commencement of the Offer, or if Stockholder has not received the requisite offer documents by such time, within two
(2) business days following receipt of such documents but in any event prior to the date of expiration of the Offer, free and clear of any Liens whatsoever on title, transfer, or exercise of any rights of a stockholder in respect of such
Shares, (ii) not withdraw its Shares, or cause its Shares to be withdrawn, from the Offer at any time, unless and until this Agreement shall have 

  

 -2- 

 
been terminated in accordance with Section 13(d) and (iii) duly tender to Purchaser during any “subsequent offering period” (as
defined by Rule 14d-11 under the Exchange Act) provided by Purchaser in accordance with the terms of the Offer all of the Stockholder’s Shares, if any, which shall have been issued after the expiration of the Offer. 
 (ii) If the Offer is terminated or withdrawn by Purchaser, or the Merger Agreement is terminated prior to the purchase of the Shares in
the Offer, Parent and Purchaser shall promptly return, and shall cause any depository acting on behalf of Parent and Purchaser to return, all tendered Shares to the registered holders of the Shares tendered in the Offer (and in connection with the
foregoing, the Purchaser will direct the depository to so return such tendered Shares within three business days of any such termination or withdrawal). 
 (b) Exercise and Cancellation of Warrants.1 
 (i) Stockholder hereby acknowledges and agrees that, in
the event that (A) Stockholder does not exercise all of its Warrants prior to the Acceptance Time and (B) the Acceptance Time occurs, then Stockholder will not exercise any of its Warrants following the Acceptance Time and will take all
actions necessary (including entering into an amendment to the terms thereof) to permit the conversion of all such Warrants into cash consideration in connection with the Merger as contemplated by Section 2(b)(ii). 
 (ii) Stockholder hereby acknowledges and agrees that, to the extent that any of Stockholder’s Warrants remain outstanding
immediately prior to the Effective Time, whether or not any such Warrant is then exercisable, (a) each such Warrant shall automatically be cancelled or terminated immediately prior to the Effective Time (but subject to the occurrence thereof)
and shall cease to represent a right of the holder of such Warrant to acquire Common Stock pursuant to the exercise of such Warrant, and (b) the holder of such Warrant shall be entitled to receive, upon surrender of such holder’s Warrants
to the Company, a cash payment equal to the product of (x) the excess, if any, of the Offer Price per share of Common Stock over the exercise price per Share of such Warrant and (y) the number of Shares subject to the exercisable portion
of such Warrant, as the sole form of consideration in exchange for surrender of each such Warrant, without interest and subject to any applicable withholding taxes, and (c) Stockholder shall not have any right after the Effective Time under the
terms of any of its Warrants to acquire any securities of the Company, Parent, Purchaser or the entity surviving the Merger (or any other capital stock or other assets of any Person). In the event the Offer Price does not exceed the exercise price
per Share of any Warrant, such Warrant shall be cancelled without consideration at the Effective Time. 
 (iii)
Notwithstanding Section 13(d), in the event the Acceptance Time occurs, this Section 2(b) shall survive the Acceptance Time indefinitely. 
 Section 3. Documentation and Information. Stockholder (a) consents to and 
  
  

	 1
	 This provision will be included if the tendering stockholder owns warrants. 

  

 -3- 

 
authorizes the publication and disclosure by Parent and Purchaser of Stockholder’s identity and holding of Shares and Warrants, the nature of
Stockholder’s commitments, arrangements and understandings under this Agreement (including, for the avoidance of doubt, the disclosure of this Agreement) and any other information, in each case, that Parent or Purchaser determines based on
advice of counsel is required to be disclosed by applicable Law in any press release, the Offer Documents, the Proxy Statement (including all schedules and documents filed with the SEC), or any other disclosure document in connection with the Offer,
the Merger and any transactions contemplated by the Merger Agreement and (b) agrees to promptly give to Parent and Purchaser any information it may reasonably require for the preparation of any such disclosure documents. Stockholder agrees to
promptly notify Parent and Purchaser of any required corrections with respect to any information supplied by Stockholder specifically for use in any such disclosure document, if and to the extent that any such information shall have become false or
misleading in any material respect. 
 Section 4. Voting Agreement. During the Agreement Period, Stockholder hereby irrevocably and
unconditionally agrees that at any meeting (whether annual or special and whether or not an adjourned or postponed meeting) of the holders of Common Stock, however called (each, a “Company Stockholders Meeting”), or in connection
with any written consent of the holders of Common Stock, Stockholder shall: 
 (a) be present, in person or represented by proxy, or otherwise
cause Stockholder’s Shares to be counted for purposes of determining the presence of a quorum at such meeting (to the fullest extent that such Shares may be counted for quorum purposes under applicable Law); and 
 (b) vote (or cause to be voted) all of Stockholder’s Shares that are entitled to be voted (the “Vote Shares”), or deliver a written
consent (or cause a written consent to be delivered) with respect to all of Stockholder’s Vote Shares, in each case, to the fullest extent that Stockholder’s Vote Shares shall be entitled to be voted at the time of any vote or action by
written consent: 
 (i) in favor of the (A) approval and adoption of the Merger Agreement, the Merger and each of the
other actions contemplated by the Merger Agreement, and, (B) without limitation of the preceding clause (A), approval of any proposal to adjourn or postpone the Company Stockholders Meeting to a later date if there are not sufficient votes for
approval and adoption of the Merger Agreement on the date on which the Company Stockholders Meeting is held; and 
 (ii)
against (A) any action (including any amendment to the Company Certificate or Company By-Laws, as in effect on the date hereof), agreement or transaction that would reasonably be expected to frustrate the purposes of, impede, hinder, interfere
with, nullify, prevent, delay or adversely affect the consummation of the transactions contemplated by the Merger Agreement, including the Offer, (B) any Competing Proposal and any action in furtherance of any Competing Proposal, (C) any
merger, acquisition, sale, consolidation, reorganization, recapitalization, extraordinary dividend, dissolution, liquidation or winding up of or by the Company, or any other extraordinary transaction involving the Company (other than the Merger) and
(D) any 

  

 -4- 

 
action, proposal, transaction or agreement that would reasonably be expected to result in a breach of any covenant, representation or warranty or any other
obligation or agreement of Stockholder under this Agreement or, to the Stockholder’s knowledge, of the Company under the Merger Agreement. 
 Section 5. Irrevocable Proxy. Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that it has heretofore granted. Stockholder hereby irrevocably appoints Parent as attorney-in-fact and proxy for and on behalf of
Stockholder, for and in the name, place and stead of Stockholder, to: (a) attend any and all Company Stockholder Meetings, (b) vote, express consent or dissent or issue instructions to the record holder to vote Stockholder’s Shares in
accordance with the provisions of Section 4(b) at any and all Company Stockholder Meetings or in connection with any action sought to be taken by written consent of the Company’s stockholders without a meeting and (c) grant or
withhold, or issue instructions to the record holder to grant or withhold, consistent with the provisions of Section 4, all written consents with respect to the Shares at any and all Company Stockholder Meetings or in connection with any
action sought to be taken by written consent without a meeting. Parent agrees not to exercise the proxy granted herein for any purpose other than the purposes described in this Agreement. The foregoing proxy shall be deemed to be a proxy coupled
with an interest, is irrevocable (and as such shall survive and not be affected by the death, incapacity, mental illness or insanity of Stockholder, as applicable) until the end of the Agreement Period and shall not be terminated by operation of Law
or upon the occurrence of any other event other than the termination of this Agreement pursuant to Section 13(d). Stockholder authorizes such attorney and proxy to substitute any other Person to act hereunder, to revoke any substitution
and to file this proxy and any substitution or revocation with the Secretary of the Company. Stockholder hereby affirms that the proxy set forth in this Section 5 is given in connection with and granted in consideration of and as an
inducement to Parent and Purchaser to enter into the Merger Agreement and that such proxy is given to secure the obligations of the Stockholder under Section 4. The proxy set forth in this Section 5 is executed and intended
to be irrevocable, subject, however, to its automatic termination upon the termination of this Agreement pursuant to Section 13(d). Parent covenants and agrees with Stockholder that Parent will exercise the foregoing proxy consistent
with the provisions of Section 4. 
 Section 6. Representations and Warranties of Stockholder. Stockholder represents and
warrants to each of Parent and Purchaser as follows (it being understood that, except where expressly stated to be given or made as of the date hereof only, the representations and warranties contained in this Agreement shall be made as of the date
hereof, as of the date of each Company Stockholders Meeting, as of the date of any applicable action taken by written consent of the Company’s stockholders and as of the Acceptance Time): 
 (a) Organization. Stockholder, if it is a corporation, partnership, limited liability company, trust or other entity, is duly organized, validly
existing and in good standing under the Laws of the jurisdiction in which it is incorporated or constituted. 
 (b) Authorization. If
Stockholder is not an individual, it has full corporate, limited liability company, partnership or trust power and authority to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions
contemplated hereby. If Stockholder is an individual, he or she has full legal capacity, right and 

  

 -5- 

 
authority to execute and deliver this Agreement and to perform his or her obligations hereunder and to consummate the transactions contemplated hereby. To
the extent applicable, the execution, delivery and performance by Stockholder of this Agreement and the consummation by Stockholder of the transactions contemplated hereby have been duly and validly authorized by all necessary action on the part of
Stockholder (and its board of directors or similar governing body, as applicable), and no other actions or proceedings on the part of Stockholder (or its board of directors or similar governing body, as applicable) are necessary to authorize the
execution and delivery by Stockholder of this Agreement and the consummation by Stockholder of the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Stockholder and constitutes a valid and legally
binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting
creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law). 
 (c) No
Violation. 
 (i) The execution and delivery of this Agreement by Stockholder does not, and the performance by Stockholder
of Stockholder’s obligations hereunder and the consummation by Stockholder of the transactions contemplated hereby will not, (i) conflict with, or result in any violation or breach of, or constitute a default (with or without notice or
lapse of time, or both) under, or give rise to a right of, or result by its terms in the, termination, amendment, cancellation or acceleration of any obligation or the loss of a material benefit under, or to increased, additional, accelerated or
guaranteed rights or entitlements of any Person under, or create any obligation to make a payment to any other Person under, or result in the creation of a Lien on, or the loss of, any of the properties or assets of Stockholder (including
Stockholder’s Shares or Warrants) pursuant to (A) if Stockholder is not an individual, any provision of its articles of incorporation, bylaws or similar organizational documents or (B) any contract, trust, commitment, agreement,
understanding, arrangement, obligation or restriction of any kind (each, a “Contract”) to which Stockholder is a party or by which any of Stockholder’s Shares or Warrants is bound, or (ii) violate any Law applicable to
Stockholder, in each case, except as would not, individually or in the aggregate, reasonably be expected to prevent, delay, impair or otherwise adversely affect the ability of Stockholder to perform its obligations hereunder or consummate the
transactions contemplated hereby. 
 (ii) No consent, approval, order, authorization or permit of, or registration,
declaration or filing with or notification to, any Governmental Entity or any other Person is required by or with respect to Stockholder in connection with the execution and delivery of this Agreement by Stockholder or the performance by Stockholder
of Stockholder’s obligations hereunder, except for the filing with the SEC of any Schedules 13D or 13G or amendments to Schedules 13D or 13G and filings under Section 16 of the Exchange Act and filings under the HSR Act, as may be required
in connection with this Agreement and the transactions contemplated hereby. 
 (d) Ownership of Shares. Stockholder is, and (except
with respect to any Schedule A Shares Transferred (as hereinafter defined) in accordance with Section 8(b)) at all 

  

 -6- 

 
times during the Agreement Period will be, the beneficial owner of, and have good and marketable title to, Stockholder’s Schedule A Shares and Schedule
A Warrants, other than as such beneficial ownership or title may be effected by the terms of this Agreement. As of the date hereof, Stockholder’s Schedule A Shares and Schedule A Warrants constitute all of the Shares and Warrants beneficially
owned by Stockholder (other than shares beneficially owned in the form of Company Options or restricted stock but only to the extent such shares remain unvested, restricted or unexercised, as the case may be). Other than as provided in this
Agreement, Stockholder has, and (except with respect to any Shares Transferred in accordance with Section 8(b)) at all times during the Agreement Period will have, with respect to Stockholder’s Shares and Warrants, the sole power,
directly or indirectly, to vote, dispose of, exercise and convert, as applicable, such Shares and Warrants, and to demand or waive any appraisal rights or issue instructions pertaining to such Shares with respect to the matters set forth in this
Agreement, in each case with no limitations, qualifications or restrictions on such rights, and, as such, has, and (except with respect to any Shares Transferred in accordance with Section 8(b)) at all times during the Agreement Period
will have, the complete and exclusive power to, directly or indirectly, (A) issue (or cause the issuance of) instructions with respect to the matters set forth in Section 4, (B) agree to all matters set forth in this Agreement
and (C) demand and waive appraisal or dissent rights. As of the date hereof, Stockholder’s Schedule A Shares are issued and outstanding and entitled to be voted at the Company Stockholder Meeting and, other than Stockholder’s Schedule
A Warrants, Stockholder does not beneficially own any warrants, options (other than Company Options to purchase up to [1,126,198 in the case of Alan H. Auerbach, 694,031 in the case of Arie S. Belldegrun, 0 in the case of Horizon BioMedical
Ventures, LLC] Shares) or other rights to acquire any shares of Common Stock. Stockholder’s Schedule A Shares and Schedule A Warrants and all other Shares and Warrants of which Stockholder acquires beneficial ownership during the Agreement
Period, shall at all times be free and clear of any Liens, proxies, powers of attorney, voting trusts or agreements (other than Liens or proxies created by this Agreement). Except as provided in this Agreement, there are no agreements or
arrangements of any kind, contingent or otherwise, to which Stockholder is a party obligating Stockholder to Transfer or cause to be Transferred, any of Stockholder’s Shares. Except pursuant to this Agreement, no Person has any contractual or
other right or obligation to purchase or otherwise acquire any of Stockholder’s Shares. 
 (e) Absence of Litigation. With
respect to Stockholder, as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of Stockholder, threatened against or affecting, Stockholder or any of its properties or assets (including
Stockholder’s Shares or Warrants) that could reasonably be expected to impair the ability of Stockholder to perform its obligations hereunder or to consummate the transactions contemplated hereby on a timely basis. 
 (f) Opportunity to Review; Reliance. Stockholder has had the opportunity to review the Merger Agreement and this Agreement with counsel of its own
choosing. Stockholder understands and acknowledges that Parent and Purchaser are entering into the Merger Agreement in reliance upon Stockholder’s execution, delivery and performance of this Agreement. 
 (g) Finders’ Fees. No investment banker, broker, finder or other intermediary is entitled to a fee or commission from Parent, Purchaser or
the Company in respect of this 

  

 -7- 

 
Agreement based upon any arrangement or agreement made by or on behalf of Stockholder in its capacity as such. 
 Section 7. Representations and Warranties of Parent and Purchaser. Each of Parent and Purchaser hereby, severally and not jointly, represents and
warrants to Stockholder as follows: 
 (a) Organization. Such party is an entity duly organized, validly existing and in good standing
under the Laws of the jurisdiction in which it is incorporated, and it has all requisite corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder and consummate the transactions contemplated
hereby, and has taken all necessary corporate action to authorize the execution, delivery and performance of this Agreement. 
 (b)
Authorization. This Agreement has been duly authorized, executed and delivered by each such party, and constitutes a valid and binding obligation of such party enforceable in accordance with its terms, subject to the effects of bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law). 
 Section 8. No Proxies for or Liens on Shares; Transfers. 
 (a) Except pursuant to the terms of this Agreement, during the Agreement Period, Stockholder shall not without the prior written consent of Parent, directly or indirectly, (i) grant any proxies, powers of
attorney, rights of first offer or refusal, or enter into any voting trust or voting agreement or arrangement with respect to any of the Shares, (ii) sell (including short sell), assign, transfer, tender, pledge, encumber, grant a participation
interest in, hypothecate or otherwise dispose of (including by gift) (each, a “Transfer”) any of Stockholder’s Shares or Warrants, (iii) otherwise permit any Liens to be created on any of Stockholder’s Shares or
Warrants, or (iv) enter into any Contract (including any derivative, hedging or other agreement), option or other arrangement (including any profits sharing arrangement) or understanding with respect to the direct or indirect Transfer of any of
Stockholder’s Shares or Warrants. Without limiting the foregoing, Stockholder shall not take any other action that would in any way restrict, limit or interfere in any material respect with the performance of Stockholder’s obligations
hereunder or the transactions contemplated by the Merger Agreement. 
 (b) Notwithstanding the foregoing, Stockholder shall have the right to
Transfer its Shares to a Permitted Transferee of Stockholder if and only if such Permitted Transferee shall have first agreed in writing, in a manner acceptable in form and substance to Parent, to be bound by this Agreement as a Stockholder.

 (c) Stockholder shall not request that the Company register the Transfer (book-entry or otherwise) of any certificate or uncertificated
interest representing any of Stockholder’s Shares, unless such Transfer is made in compliance with this Agreement. Stockholder hereby authorizes each of Parent and Purchaser to direct the Company to impose stop orders to prevent the Transfer of
any Shares on the books of the Company in violation of 

  

 -8- 

 
this Agreement. 
 Section 9. Waiver of
Appraisal Rights. Stockholder hereby irrevocably waives any and all rights it may have as to appraisal, dissent or any similar or related matter with respect to any of Stockholder’s Shares that may arise with respect to the Merger or any of
the transactions contemplated by the Merger Agreement. Notwithstanding Section 13(d), in the event the Acceptance Time occurs, this Section 9 shall survive the Acceptance Time indefinitely. 
 Section 10. Notices of Certain Events. Stockholder shall promptly notify Parent of any development occurring after the date hereof that causes, or
that would reasonably be expected to cause, any breach of any of the representations and warranties of Stockholder set forth in this Agreement. 
 Section 11. Further Assurances. Parent and Stockholder will each execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to
be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to perform their respective obligations under and consummate the transactions contemplated by this Agreement. 
 Section 12. Certain Adjustments. In the event of a stock split, stock dividend or distribution, or any change in the Common Stock by reason of a
stock split, reverse stock split, recapitalization, combination, merger, consolidation, reorganization, reclassification, readjustment, exchange of shares or the like, the terms “Schedule A Shares” and “Shares”
shall be deemed to refer to and include such shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are received in the transaction.

 Section 13. Miscellaneous. 
 (a)
Notices. All notices and other communications to any party hereunder shall be in writing and shall be deemed duly given if delivered personally (notice deemed given upon receipt), sent by telecopier or facsimile (notice deemed given upon
confirmation of receipt), sent by nationally recognized overnight courier (notice deemed given upon receipt of proof of delivery) or sent by registered or certified mail, return receipt requested, postage prepaid (notice deemed given upon receipt of
proof of delivery), in each case, to the parties at the following addresses or facsimile numbers (or at such other address or facsimile number for a party as shall be specified by like notice): 
 If to Parent or Purchaser: 
 Johnson & Johnson 
 One Johnson & Johnson Plaza 
 New Brunswick, New Jersey 08933 
 Attention:    Office of the General Counsel 
 Facsimile:    (732) 524-2788 
 with a copy (which shall not constitute notice) to: 
  

 -9- 

 Cravath, Swaine & Moore LLP 
 825 Eighth Avenue 
 New York, New York 10019

 Telephone: (212) 474-1964 
 Facsimile: (212) 474-1000 
 Attention: Robert I. Townsend III, Esq. 
   Damien R. Zoubek, Esq. 
 If to
the Stockholder, to its address set forth on a signature page hereto. 
 All such notices and other communications shall be deemed received
on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed to have been received on the next succeeding business day
in the place of receipt. Nothing in this Section 13(a) shall be deemed to constitute consent to the manner or address for service of process in connection with any legal proceeding, including litigation arising out of or in connection
with this Agreement. 
 (b) Entire Agreement; No Third Party Beneficiaries; Amendment; Waiver. 
 (i) This Agreement constitutes the entire agreement, and supersedes all prior (written or oral) understandings, agreements or
representations, by or among the parties hereto with respect to the subject matter hereof. 
 (ii) This Agreement shall not
confer any rights, benefits or remedies of any nature whatsoever upon any Person other than the parties hereto and their respective permitted successors and permitted assigns. 
 (iii) This Agreement may only be amended, modified or supplemented by a written instrument executed and delivered by Parent and
Stockholder. 
 (iv) Any party or parties hereto may, to the extent legally allowed, (A) extend the time for the
performance of any of the obligations or other acts of the other party or parties hereto, as applicable, or (B) waive compliance with any of the agreements for the benefit of such party or parties hereto contained herein. Any agreement on the
part of a party or parties hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party or parties, as applicable. Any failure or delay in exercising any right under this
Agreement shall not constitute a waiver of such right nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. 
 (c) Assignment; Binding Effect. Subject to Section 8(b), neither Stockholder, on the one hand, nor Parent or Purchaser, on the other
hand, may assign this Agreement or any of its rights, interests or obligations hereunder (whether by operation of Law or otherwise) without the prior written approval of Parent or Stockholder, as applicable, and any attempted assignment without such
prior written approval shall be void and without legal effect; provided, however, that Parent and Purchaser may each assign their respective rights and obligations hereunder to a 

  

 -10- 

 
direct or indirect wholly-owned Subsidiary of such Person, it being understood and agreed that any such assignment shall not relieve such Person of its
obligations hereunder. Subject to the preceding sentence, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective permitted successors and permitted assigns. 
 (d) Termination. This Agreement shall automatically terminate and become void and of no further force or effect on the earlier to occur of any of
the following events (i) the Effective Time, (ii) the Offer shall have terminated or the Expiration Time shall have occurred, in each case without acceptance for payment of Shares pursuant to the Offer, and (iii) the termination of
the Merger Agreement in accordance with its terms (the time of such occurrence, the “Termination Time”); provided, however, that (A) Section 13 shall survive any termination hereof,
(B) Section 2(b) and Section 9 shall survive any termination hereof in the event the Acceptance Time has occurred and (C) no such termination shall relieve or release Stockholder, Parent or Purchaser from any
obligations or liabilities arising out of its breach of this Agreement prior to its termination. 
 (e) Governing Law; Consent to
Jurisdiction; Waiver of Jury Trial. 
 (i) This Agreement shall be governed by, and construed in accordance with, the laws
of the State of Delaware, without giving effect to conflicts of laws principles that would result in the application of the Law of any other state. 
 (ii) Each of the parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Delaware Court of Chancery, or, if such state court does not have
proper jurisdiction, the federal court of the United States of America, sitting in Delaware, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the agreements delivered in connection
herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any judgment relating thereto, and each of the parties hereby irrevocably and unconditionally (A) agrees not to commence any such action or
proceeding except in such courts, (B) agrees that any claim in respect of any such action or proceeding may be heard and determined in such Delaware Court of Chancery or, if no such state court has proper jurisdiction, in such federal court,
(C) waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any such action or proceeding in any such Delaware Court of Chancery or federal court and
(D) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such Delaware Court of Chancery or federal court. Each of the parties hereto agrees that a final
judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party to this Agreement irrevocably consents to service of process in the
manner provided for notices in Section 13(a). Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by Law. 
 (iii) EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY 

  

 -11- 

 
JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY, AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 13(e)(iii). 
 (f) Severability. If any term or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or
incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law in an
acceptable manner to the end that the original intent of the parties are fulfilled to the extent possible. 
 (g) Specific
Performance. Each of the parties hereto agrees that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that the parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court specified in Section 13(e)(ii),
without bond or other security being required, this being in addition to any other remedy to which they are entitled at Law or in equity. Except as otherwise provided herein, any and all rights and remedies herein expressly conferred upon a party
will be deemed cumulative with and not exclusive of any other right or remedy conferred hereby, or by Law or equity upon such party, and the exercise by a party of any one right or remedy will not preclude the exercise of any other right or remedy.

 (h) Expenses. All costs and expenses incurred in connection with this Agreement shall be paid by or on behalf of the party
incurring such cost or expense, whether or not the transactions contemplated by this Agreement or the Merger Agreement are consummated. 
 (i) Counterparts. This Agreement may be executed manually or by facsimile by the parties hereto, in any number of counterparts (each of which shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement) and shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto. 
 (j) Headings. The Section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. 
  

 -12- 

 (k) Interpretation. Any reference to any national, state, local or foreign Law shall be deemed
also to refer to all rules and regulations promulgated thereunder, unless the context otherwise requires. When a reference is made in this Agreement to Sections or Schedules, such reference shall be to a Section of or Schedule to this Agreement
unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” In this Agreement, the
Stockholder of any Common Stock held in trust shall be deemed to be the relevant trust and/or the trustees thereof acting in their capacities as such trustees, in each case as the context may require to be most protective of Parent, including for
purposes of such trustees’ representations and warranties as to the proper organization of the trust, their power and authority as trustees and the non-contravention of the trust’s governing instruments. 
 (l) No Presumption. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against
the party drafting or causing any instrument to be drafted. 
 (m) No Limitation on Actions as Director. Notwithstanding any other
provision of this Agreement, nothing in this Agreement is intended to, or shall be construed to, prohibit a Stockholder, or any officer or Affiliate of a Stockholder who is a director of the Company, from taking any action in his or her capacity as
a member of the Company Board of Directors or from exercising his or her fiduciary duties as a member of the Company Board of Directors. 
 [signature pages follow] 
  

 -13- 

 The parties hereto have executed this Tender and Support Agreement as of the date first written above.

  

			
	JOHNSON & JOHNSON
		
	By:	 	 
	Name:	 	Sherilyn S. McCoy
	Title:	 	Worldwide Chairman, Pharmaceuticals Group

  

			
	KITE MERGER SUB, INC.
		
	By:	 	 
	Name:	 	William Hait
	Title:	 	President

  

					
		  		  	
		  		  	[Stockholder]
		  		  	
		  		  	Address:
		  		  	[•]
		  		  	[•]
		  		  	Facsimile: [•]
		  		  	
		  		  	with copies (which shall not constitute notice) to:
		  		  	
		  		  	[•]
		  		  	[•]
		  		  	[•]
		  		  	Attention: [•]
		  		  	Facsimile: [•]

  

 -14- 

 SCHEDULE A 
  

					
	 NAME
	  	NUMBER OF
SHARES	 	NUMBER OF
WARRANTS
	 [Horizon BioMedical Ventures, LLC]
	  	[3,184,903]	 	[0]
	 [Alan H. Auerbach]
	  	[288,083]	 	[0]
	 [Arie S. Belldegrun]
	  	[359,112]	 	[35,699]

  

 -15-Second Amendment to Stock Purchase Agreement

 Exhibit 10.1 
 SECOND AMENDMENT TO 
 STOCK PURCHASE AGREEMENT 
 This Second Amendment to Stock Purchase Agreement (this “Amendment”), is made and entered into as of May 22, 2009, by and
between The Colonial BancGroup, Inc., a Delaware corporation (the “Company”) and Taylor, Bean & Whitaker Mortgage Corp., a Florida corporation (“TBW” and, together with each of the Purchasers listed on
Schedule 1 of the Purchase Agreement referred to below, each a “Purchaser” and collectively, “Purchasers”). 
 W I T N E S S E T H: 
 WHEREAS, the Company and
TBW executed and delivered that certain Stock Purchase Agreement, dated as of March 31, 2009, as amended by that certain First Amendment to Stock Purchase Agreement, dated as of April 30, 2009 (as so amended, the “Purchase
Agreement”; capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement); and 
 WHEREAS, the Company and TBW now wish to amend the Purchase Agreement to, among other things, provide that all of the purchased shares will be voting stock and revise the post-Closing composition of the Company
Board, all as more particularly set forth herein. 
 NOW THEREFORE, in consideration of the foregoing recitals and the mutual
promises, representations, warranties, covenants and agreements set forth herein, the parties hereto agree as follows: 
 Section 1.
Amendment to Index of Defined Terms. The Index of Defined Terms portion of the Purchase Agreement is hereby amended by deleting the reference to the term “Series B Stock.” 
 Section 2. Amendment to Recitals. The Recitals portion of the Purchase Agreement is hereby amended by deleting the existing Recital in
its entirety, and substituting in lieu thereof the following Recital: 
 “WHEREAS, the Company desires to issue
and sell to Purchasers, and Purchasers desire to purchase from the Company, certain shares of the Company’s Series A Voting Convertible Preferred Stock, par value $2.50 per share (the “Series A Stock” or the “Preferred
Stock”), on the terms set forth herein.” 
 Section 3. Amendments to Article 1 (Preferred Stock).

 (a) Section 1.1 of the Purchase Agreement is hereby amended by deleting the existing Section 1.1 in its entirety and substituting
in lieu thereof the following new Section 1.1: 
 “1.1 Agreement to Sell and Purchase. Subject to the
terms and conditions hereof, Purchasers agree to purchase from the Company, on the Closing Date, an aggregate of 600,000 shares of Series A Stock (the “Shares”), and the Company agrees to 

 
issue and sell such Shares to Purchasers, at a price of Five Hundred and no/100 Dollars ($500.00) per Share (the “Price Per Share”) for an
aggregate purchase price (the “Purchase Price”) equal to Three Hundred Million and no/100 Dollars ($300,000,000.00) (such issuance, sale and purchase of the Shares, along with the other commitments by the parties set forth in this
Agreement is referred to herein as the “Transaction”).” 
 (b) Section 1.2 of the Purchase
Agreement is hereby amended as follows: 
 (i) The first sentence of such Section 1.2 shall be deleted in its entirety
and replaced by the following new first sentence of such Section 1.2: “The designations, preferences and rights of the Series A Stock shall be substantially as set forth in a Certificate of Designations (the “Certificate of
Designations”), to be filed with the Delaware Secretary of State, substantially in the form attached hereto as Exhibit A.” 
 (ii) Subsection (b) of such Section 1.2 shall be deleted in its entirety. 
 Section 4.
Amendment to Section 6.7(a) (Company Board). Section 6.7(a) of the Purchase Agreement is hereby amended by deleting such subsection in its entirety and substituting in lieu thereof the following new Section 6.7(a):

 “(a) On the Closing Date or as soon as practicable thereafter, the Company Board shall fix the number of directors at
fifteen (15), of which six individuals, selected by Purchasers (four of such six individuals to be selected by TBW) as representatives of Purchasers as set forth below (the “Board Representatives”), shall be appointed to the Company
Board and commence serving on the Company Board immediately thereafter, subject to satisfactory completion of a Directors & Officers questionnaire and provision of other background information as may be reasonably requested by the Company,
and subject to any required approvals of Regulatory Authorities. On the Closing Date or as soon as practicable thereafter, the Company shall also cause two of the Board Representatives, at the option of the Required Purchasers (one of such two
individuals to be selected by TBW), to be appointed to the Executive Committee of the Company Board (or any successor committee thereto). The Board Representatives shall be added to each class of the Company Board as the Company and Purchasers shall
mutually determine so that an approximately equal number of Board Representatives will be added to each class. Within sixty (60) days after the Closing Date, the Company shall cause the Company Board’s composition to be as follows:
(i) the six Board Representatives; (ii) five other continuing directors; and (iii) four other directors, mutually agreeable to the Company and Purchasers. On the Closing Date or as soon as practicable thereafter, the Company shall
cause Colonial Bank to fix the number of directors on the board of Colonial Bank at thirteen (13), and shall cause Colonial Bank to add the six Board Representatives to the Colonial Bank Board of Directors as well, subject to any required approvals
of Regulatory Authorities.” 
 Section 5. Amendment to Section 7.1(b) (Stock Legend). Section 7.1(b) of the
Purchase Agreement is hereby amended by deleting the phrase “TBW agrees that all certificates or other instruments representing Shares of Series B Stock will bear a legend substantially to the following effect:” and deleting the stock
legend contained in the three paragraphs below such phrase. 

 Section 6. Amendment to Exhibit A (Form of Certificate of Designations). The existing
Exhibit A to the Purchase Agreement is hereby deleted in its entirety and replaced with the Exhibit A attached hereto. 
 Section 7. Amendment to Schedule 1 (Purchasers). The existing Schedule 1 to the Purchase Agreement is hereby deleted in its entirety and replaced with the Schedule 1 attached hereto. 
 Section 8. Future References. All future references to the Purchase Agreement shall be deemed to refer to the Purchase Agreement as
amended hereby. 
 Section 9. No Other Changes. Except as expressly amended and modified herein, all terms, covenants and
provisions of the Purchase Agreement shall remain unaltered and in full force and effect, and the parties hereto expressly ratify and confirm the Purchase Agreement as modified herein. 
 Section 10. Entire Agreement. This Amendment constitutes the full and entire understanding and agreement between the parties with
regard to the subjects hereof and thereof, and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth herein or therein. 
 Section 11. Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be enforceable against the
parties actually executing such counterparts, and all of which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or by PDF formatted page sent by electronic mail shall be
effective as delivery of a manually executed counterpart of this Amendment. 
 [SIGNATURES BEGIN ON NEXT PAGE] 

 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Amendment as of the
date first above written. 
  

			
	 COMPANY:
  
 THE COLONIAL BANCGROUP, INC.

		
	By:	 	 /s/    Robert E. Lowder

	Name:	 	Robert E. Lowder
	Title:	 	CEO & President
	
	 TBW:
  
 TAYLOR, BEAN & WHITAKER
 MORTGAGE CORP.

		
	By:	 	 /s/    Lee B. Farkas

	Name:	 	Lee B. Farkas
	Title:	 	Chairman

 Exhibit A 
 Form of Certificate of Designations 
 [SEE ATTACHED] 

 CERTIFICATE OF DESIGNATIONS OF 
 SERIES A VOTING CONVERTIBLE PREFERRED STOCK 
 OF 
 THE COLONIAL BANCGROUP, INC. 
 Pursuant
to Section 151 of the 
 General Corporation Law of the State of Delaware 
  
  
 THE COLONIAL BANCGROUP, INC., a Delaware corporation (the “Corporation”), certifies as follows: 
 FIRST: The Amended and Restated Certificate of Incorporation of the Corporation (the “Certificate of Incorporation”) authorizes the
issuance of One Million (1,000,000) shares of Preference Stock, par value $2.50 per share, and, further, authorizes the Board of Directors of the Corporation, subject to the limitations prescribed by law and the provisions of such Certificate
of Incorporation, to provide for the issuance of shares of the Preference Stock or to provide for the issuance of shares of the Preference Stock in one or more series, to establish from time to time the number of shares to be included in each such
series and to fix the designations, voting powers, preference rights and qualifications, limitations or restrictions of the shares of the Preference Stock of each such series. 
 SECOND: The Board of Directors of the Corporation, at a special meeting duly called on and held on
            , 2009, duly adopted the following resolutions, authorizing the creation and issuance of a series of Preference Stock, to be known as Series A Voting Convertible
Preferred Stock: 
 RESOLVED, that the Board of Directors, pursuant to the authority vested in it by the provisions of the Certificate of
Incorporation of the Corporation, hereby authorizes the issuance of a series of the Corporation’s Preference Stock, par value $2.50 per share, Six Hundred Thousand (600,000) shares of which are authorized to be issued under the
Corporation’s Certificate of Incorporation and being designated as Series A Voting Convertible Preferred Stock (hereinafter referred to as the “Series A Preferred Stock”); and further 

 RESOLVED, that the Board of Directors hereby fixes the number, designations, preferences, rights and
limitations of the Series A Preferred Stock, in addition to those set forth in said Certificate of Incorporation as follows: 
 A.
Series A Voting Convertible Preferred Stock. 
 1. Designation and Amount. 
 There shall be a series of Preferred Stock designated as Series A Voting Convertible Preferred Stock (“Series A Preferred Stock”) and the
number of shares constituting such series shall be Six Hundred Thousand (600,000). Such number of shares may be increased or decreased by resolution of the Board of Directors, provided that no decrease shall reduce the number of Series A Preferred
Stock to a number less than the number of shares then outstanding or reserved for issuance in certain events. 
 2.
Dividends. 
 The holders of the outstanding Series A Preferred Stock shall be entitled to receive dividends or distributions on
an as-converted and pari passu basis with the Corporation’s now or hereafter issued Common Stock, and each other series of capital stock of the Corporation that is not, by its terms, senior to the Series A Preferred Stock, if, as and
when declared by the Board of Directors or any duly authorized committee thereof, but only out of assets legally available therefore. 
 3.
Liquidation Rights. 
 All shares of Series A Preferred Stock shall rank pari passu, on an as-converted basis, as to
distributions of assets upon the voluntary or involuntary liquidation, dissolution or winding up of the Corporation, to all of the Corporation’s now or hereafter issued Common Stock and any other series of capital stock of the Corporation that
is not, by its terms, senior to the Series A Preferred Stock. 
 4. Voting Rights. 
 The holders of Series A Preferred Stock shall have the right to vote, on an as-converted basis,
with the Common Stock on all matters as and to the extent permitted by the Delaware General Corporation Law. In connection with any such vote, each outstanding share of Series A Preferred Stock shall be entitled to a number of votes equal to the
number of shares of Common Stock into which such share of Series A Preferred Stock is then convertible pursuant to Section 6 hereof as of the record date for the vote or written consent of stockholders, if applicable, which is initially one
thousand (1,000) votes per share. So long as any Series A Preferred Stock is outstanding, the Corporation shall not, without the affirmative vote of the holders of at least 66 2/3 percent of all outstanding shares of Series A Preferred Stock, voting separately as a class, whether or not a vote of the stockholders would otherwise be required by law, (i) amend, alter
or repeal (by merger or otherwise) any provision of the Certificate of Incorporation or the Bylaws of the Corporation so as to affect adversely the relative rights, preferences, qualifications, limitations or restrictions of the Series A Preferred
Stock (other than to create or establish any capital stock issued or to be issued to the United States Treasury as part of the TARP Capital Purchase Program or any similar governmental program), (ii) authorize or issue, or increase the
authorized amount of, any additional class or series of stock of the Corporation, or any security convertible into stock of such class or series, having rights senior to or pari passu with the Series A Preferred Stock as to dividends or
liquidation (other than any capital stock issued to the United States Treasury as part of the TARP Capital Purchase Program or any similar governmental program) and any right to vote, whether as a separate class or otherwise, on any matter (other
than a matter that can have no effect on the rights of the Series A Preferred Stock) as to which the Series A Preferred Stock is not entitled to vote, (iii) effect any reclassification of the Series A Preferred Stock, or (iv) enter
into a merger or consolidation with, or sell or transfer all or substantially all of its assets to, another person or entity. 

 5. Redemption. 
 The Corporation has no optional or mandatory redemption, retirement or sinking fund obligation with respect to the Series A Preferred Stock. 
 6. Conversion. 
 (a) Date of
Conversion. Each share of Series A Preferred Stock shall be convertible, at the option of the holder thereof, into Common Stock as provided in and pursuant to Section 6(b) below, no later than the later of (A) the date of the
Corporation’s receipt of Stockholder Approval or the date that is three months after the date of issuance of such share or (B) the date that is three months after the date of issuance of such share provided that Stockholder Approval has
been received; provided, however, that in no event will such conversion take place if there are an insufficient number of authorized shares of Company Common Stock to effectuate such conversion. “Stockholder Approval” means the
approval of the Corporation’s stockholders of an amendment to the Certificate of Incorporation (i) increasing the number of authorized shares of Common Stock so that there will be a sufficient number of authorized shares of Common Stock to
satisfy the conversion rights of all holders of the shares of Series A Preferred Stock and any other holders of the Corporation’s Preferred Stock or Preference Stock having conversion rights, (ii) reducing the par value of Common Stock to
$0.01 per share, and (iii) authorizing any amendments required by the TARP Capital Purchase Program or any similar governmental program. 
 (b) Effect of Conversion. Upon the occurrence of a conversion as provided in Section 6(a) above, the holder of shares of converted Series A Preferred Stock shall be entitled to receive 1,000
shares of Common Stock of the Corporation for each share of such converted Series A Preferred Stock, subject to adjustment as provided in Section 6(d) below. From and after any conversion of Series A Preferred Stock, all rights of the
holders of converted Series A Preferred Stock shall cease, except the right to receive Common Stock as provided in this Section 6(b). 
 (c) Conversion Procedures. Any holder of shares of Series A Preferred Stock desiring to convert such shares shall surrender the certificate or certificates for such shares of Series A Preferred Stock at the Corporation’s
principal office, which certificate or certificates, if the Corporation shall so require, shall be duly endorsed to the Corporation or in blank, or accompanied by proper instruments of transfer to the Corporation or in blank, accompanied by
irrevocable written notice to the Corporation that the holder elects so to convert such shares of Series A Preferred Stock and specifying the name or names (with address) in which a certificate or certificates for Common Stock are to be issued.
Following such conversion of the shares of Series A Preferred Stock described above, certificates that, until such conversion, represented Series A Preferred Stock (“Former Series A Certificates”) shall thereafter represent solely
the right to receive the securities and/or other property to which the holders of such certificates became entitled upon such conversion. However, such holders shall not be entitled to certificates representing any such securities or to receive any
such other property except upon surrender of such Former Series A Certificates at the Corporation’s principal office. 
 The
Corporation will, as soon as practicable after receipt of certificates for Series A Preferred Stock accompanied by any required written notice and compliance with any other conditions herein contained, deliver to the person for whose account such
shares of Series A Preferred Stock were so surrendered, or to such person’s nominee or nominees, certificates for the number of full shares of Common Stock to which such person shall be entitled as aforesaid. Subject to the following provisions
of this paragraph, such conversion shall be deemed to have been made as of the date of such surrender of the shares of Series A Preferred Stock to be converted, and the person or persons entitled to receive the Common Stock deliverable upon
conversion of such Series A Preferred Stock shall be treated for all purposes as the record holder or holders of such Common Stock on such date; provided, however, that the 

 
Corporation shall not be required to convert any shares of Series A Preferred Stock while the stock transfer books of the Corporation are closed for any
purpose, but the surrender of Series A Preferred Stock for conversion during any period while such books are so closed shall become effective for conversion immediately upon the reopening of such books as if the surrender had been made on the date
of such reopening, and the conversion shall be at the conversion rate in effect on such date. 
 (d) Adjustment. The definition
of the term “Common Stock” for purposes of this Section 6 shall be subject to adjustment from time to time in case the Corporation shall (i) pay a dividend or make a distribution on its Common Stock that is paid or
made (A) in other shares of stock of the Corporation or (B) in rights to purchase stock or other securities (other than an event described in this Section 6(d)), (ii) subdivide its outstanding shares of Common Stock into a
greater number of shares or (iii) combine its outstanding shares of Common Stock into a smaller number of shares, then in each such case the definition of “Common Stock” shall be changed so that the holder of any shares of Series A
Preferred Stock thereafter surrendered for conversion shall be entitled to receive the number of shares of Common Stock of the Corporation and other shares and rights to purchase stock or other securities which such holder would have owned or have
been entitled to receive after the happening of any of the events described above had such shares of Series A Preferred Stock been converted immediately prior to the happening of such event. An adjustment made pursuant to this
Section 6(d) shall become effective immediately after the record date in the case of a dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision or combination. In the event
that at any time, as a result of any adjustment made pursuant to this Section 6, the holder of any shares of Series A Preferred Stock thereafter surrendered by conversion shall become entitled to receive any shares of the Corporation
other than shares of Common Stock or to receive any other securities, the number of such other shares or securities so receivable upon conversion of any share of Series A Preferred Stock shall be subject to adjustment from time to time in a manner
and on terms as nearly equivalent as practicable to the provisions contained in this Section 6 with respect to the Common Stock. 
 (e) No Fractional Shares. No fractional shares or scrip representing fractional shares of Common Stock shall be issued upon conversion of Series A Preferred Stock. If more than one certificate representing shares of Series A
Preferred Stock shall be surrendered for conversion at one time by the same holder, the number of full shares issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of Series A Preferred Stock so
surrendered. Instead of any fractional share of Common Stock that would otherwise be issuable upon conversion of any shares of Series A Preferred Stock, the Corporation will pay a cash adjustment in respect of such fractional interest in an amount
equal to the same fraction of the fair market value per share of Common Stock as determined by the Board of Directors or in any manner prescribed by the Board of Directors. 
 (f) Reclassification, Consolidation, Merger or Sale of Assets. In case of any reclassification of the Common Stock, any consolidation of the
Corporation with, or merger of the Corporation into, any other person, any merger of another person into the Corporation (other than a merger that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares of
Common Stock), any sale or transfer of all or substantially all of the assets of the Corporation or any compulsory share exchange, pursuant to which share exchange the Common Stock is converted into other securities, cash or other property (any of
the foregoing being herein referred to as a “Transaction”), then lawful provision shall be made as part of the terms of such Transaction whereby the holder of each share of Series A Preferred Stock then outstanding shall have the
right to convert such share only into the kind and amount of securities, cash and other property receivable upon such Transaction by a holder of the number of shares of Common Stock of the Corporation into which such share of Series A Preferred
Stock could have been converted immediately prior to such Transaction. As a condition to the consummation of any Transaction, the Corporation shall require that the person formed by such consolidation or resulting from such merger or that acquires
such assets or that acquires the Corporation’s shares, as the case may be, 

 
shall make provisions in its certificate or articles of incorporation or other constituent documents to establish such right. Such certificate or
articles of incorporation or other constituent documents shall provide for adjustments which, for events subsequent to the effective date of such certificate or articles of incorporation or other constituent documents, shall be as nearly equivalent
as may be practicable to the adjustments provided for in this Section 6. The above provisions shall similarly apply to successive reclassifications, consolidations, mergers, sales, transfers or share exchanges. 
 (g) Reservation of Shares; Transfer Taxes; Etc. Following Stockholder Approval, the Corporation shall at all times reserve and keep
available, out of its authorized and unissued stock, solely for the purpose of effecting the conversion of the Series A Preferred Stock, such number of shares of its Common Stock and other securities free of preemptive rights as shall from time to
time be sufficient to effect the conversion of all shares of Series A Preferred Stock from time to time outstanding which are then convertible. Prior to Stockholder Approval, the Corporation shall reserve and keep available such number of shares of
its Common Stock as it then has available for such reservation for conversion. The Corporation shall from time to time, in accordance with the laws of the State of Delaware, increase the authorized number of shares of Common Stock and other
securities if at any time the number of shares of Common Stock and other securities not outstanding shall not be sufficient to permit the conversion of all the then outstanding shares of Series A Preferred Stock. The rights of the holders of the
Series A Preferred Stock, and the granting of such rights by the Corporation hereunder, shall not be considered invalid solely by reason of the lack of sufficient authorized but unissued shares to honor the exercise of such conversion rights. If any
shares of Common Stock required to be reserved for purposes of conversion of the Series A Preferred Stock hereunder require registration with or approval of any governmental authority under any Federal or State law before such shares may be issued
upon conversion or exercise, the Corporation will in good faith and as expeditiously as possible endeavor to cause such shares to be duly registered or approved, as the case may be. The Corporation will pay any and all issue or other taxes that may
be payable in respect of any issue or delivery of shares of Common Stock on conversion of the Series A Preferred Stock. The Corporation shall not, however, be required to pay any tax that may be payable in respect of any transfer involved in the
issue or delivery of Common Stock (or other securities or assets) in a name other than that in which the shares of Series A Preferred Stock so converted were registered, and no such issue or delivery shall be made unless and until the person
requesting such issue has paid to the Corporation the amount of such tax or has established, to the satisfaction of the Corporation, that such tax has been paid. 
 The Corporation shall not take any action that would cause any equity securities issuable upon conversion of Series A Preferred Stock immediately following such action to be other than fully paid and nonassessable.

 (h) Prior Notice of Certain Events. In case: 
 (i) the Corporation shall authorize the granting to the holders of Common Stock of rights or warrants to subscribe for or purchase any
shares of stock of any class or of any other rights or warrants (other than any rights specified in paragraph (d)(i)(B) of this Section 6); or 
 (ii) of any reclassification of Common Stock (other than a subdivision or combination of the outstanding Common Stock, or a change in par value, or from par value to no par value, or from no par value to par value),
or of any consolidation or merger to which the Corporation is a party and for which approval of any stockholders of the Corporation shall be required, or of the sale or transfer of all or substantially all of the assets of the Corporation or of any
compulsory share exchange whereby the Common Stock is converted into other securities, cash or other property; or 

 (iii) of the voluntary or involuntary dissolution, liquidation or winding up of the
Corporation; 
 then the Corporation shall cause to be mailed to each holder of record of the outstanding Series A Preferred Stock, at such holder’s
address as it shall appear upon the stock transfer books of the Corporation, at least 15 days prior to the applicable record date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
granting of rights or warrants or, if a record is not to be taken, the date as of which the holders of Common Stock of record to be entitled to such rights or warrants are to be determined, or (y) the date on which such reclassification,
consolidation, merger, sale, transfer, share exchange, dissolution, liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their shares
of Common Stock for securities or other property deliverable upon such reclassification, consolidation, merger, sale, transfer, share exchange, dissolution, liquidation or winding up (but neither the failure so to mail such notice nor any defect
therein or in the mailing thereof, shall affect the validity of the corporate action required to be specified in such notice). 
 7.
Preemptive Rights. 
 (a) If the Corporation offers to sell Covered Securities (as defined below) in a public or private
offering of Covered Securities solely for cash (a “Qualified Offering”), each holder of shares of Series A Preferred Stock (a “Holder”) shall be afforded the opportunity to acquire from the Corporation, for the same
price and on the same terms as such Covered Securities are offered, in the aggregate up to the amount of Covered Securities required to enable such Holder to maintain its then-current Holder Percentage Interest (as defined below), but solely to the
extent that any such issuance of shares of Covered Securities would not result in the issuance of Covered Securities that would require a vote of the stockholders of the Corporation pursuant to the listing standards of the New York Stock Exchange or
other nationally recognized stock exchange on which shares of Common Stock are listed. As used in this Section 7, (i) “Holder Percentage Interest” means, as of any date, the percentage equal to (A) the
aggregate number of shares of Common Stock beneficially owned (with the term “beneficial ownership” having the meaning ascribed in Section 13(d)(3) and Rule 13d-3 under the Exchange Act of 1934, as amended) or otherwise held by such
Holder as of such date, calculated on an as-converted basis, divided by (B) the total number of outstanding shares of Common Stock as of such date, calculated on an as-converted basis, and (ii) “Covered Securities” means
Common Stock and any securities convertible into or exercisable or exchangeable for Common Stock, other than securities that are (A) issued by the Corporation pursuant to any employment contract, employee or benefit plan, stock purchase plan,
stock ownership plan, stock option or equity compensation plan or other similar plan where stock is being issued or offered to a trust, other entity to or for the benefit of any employees, potential employees, consultants, officers or director of
the Corporation, (B) issued by the Corporation in connection with a business combination or other merger, acquisition or disposition transaction, (C) issued with reference to the Common Stock of a subsidiary of the Corporation (i.e., a
carve-out transaction), (D) issued as a dividend or in connection with a dividend reinvestment or stockholder purchase plan, (E) issued in exchange for currently outstanding securities, or (F) issued to the United States Treasury as
part of the TARP Capital Purchase Program or any similar governmental program. 
 Prior to making any Qualified Offering of Covered
Securities, the Corporation shall give each Holder written notice of its intention (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed in respect
of such), describing, to the extent then known, the anticipated amount of securities, price (or, in the case of a registered public offering, an estimated range of prices) and other material terms upon which the Corporation proposes to offer the
same. Such Holder shall have thirty (30) days from the provision of such notice to notify the Corporation in writing that it intends to exercise such preemptive purchase rights 

 
and as to the amount of Covered Securities such Holder desires to purchase, up to the maximum amount calculated pursuant to Section 7(a) (the
“Designated Securities”). Such notice shall constitute a non-binding indication of interest of such Holder to purchase the amount of Designated Securities so specified (or a proportionately lesser amount if the amount of Covered
Securities to be offered in such Qualified Offering is subsequently reduced) at the price (or range of prices) and other terms set forth in the Corporation’s notice to it. The failure by such Holder to respond during such thirty (30) day
period shall constitute a waiver of preemptive rights in respect of such offering. The obligation of the Corporation to provide such notice shall be subject to such Holder’s written agreement to confidentiality and restrictions on trading terms
reasonably acceptable to the Corporation. 
 If a Holder exercises such Holder’s preemptive purchase rights provided in this
Section 7 with respect to a Qualified Offering that is an underwritten public offering or a private offering made to qualified institutional buyers (as such term is defined in Rule 144A under the Securities Act of 1933, as amended (the
“Securities Act”) for resale pursuant to Rule 144A under the Securities Act, the Corporation shall offer such Holder, if such underwritten public offering or Rule 144A offering is consummated, the Designated Securities (as adjusted
downward or, at such Holder’s option, upward to reflect the actual size of such offering when priced) at the same price as the Covered Securities are offered to the initial purchasers in such offering and shall provide written notice of such
price to such Holder as soon as practicable prior to such consummation. Contemporaneously with the execution of any underwriting agreement or purchase agreement entered into between the Corporation and the underwriters or initial purchasers of such
underwritten public offering or Rule 144A offering, such Holder shall, if it continues to wish to exercise its preemptive rights with respect to such offering, enter into an instrument in form and substance reasonably satisfactory to the Corporation
acknowledging such Holder’s binding obligation to purchase the Designated Securities to be acquired by it and containing representations, warranties and agreements of such Holder that are customary in private placement transactions and, in any
event, no less favorable to such Holder than any underwriting or purchase agreement entered into by the Corporation in connection with such offering, and the failure to enter into such an instrument at or prior to such time shall constitute a waiver
of preemptive rights in respect of such offering. Any offers and sales pursuant to this Section 7(c) in the context of a registered public offering shall also be conditioned on reasonably acceptable representations and warranties of such
Holder regarding its status as the type of offeree to whom a private sale can be made concurrently with a registered offering in compliance with applicable securities laws. 
 If a Holder exercises its preemptive rights provided in this Section 7 with respect to a Qualified Offering that is not an underwritten
public offering or Rule 144A offering (a “Private Placement”), the closing of the purchase of the Covered Securities with respect to which such right has been exercised shall be conditioned on the consummation of the Private
Placement giving rise to such preemptive purchase rights and shall take place simultaneously with the closing of the Private Placement or on such other date as the Corporation and such Holder shall agree in writing; provided that the actual
amount of Covered Securities to be sold to such Holder pursuant to its exercise of preemptive rights hereunder shall be reduced if the aggregate amount of Covered Securities sold in the Private Placement is reduced and, at the option of such Holder
(to be exercised by delivery of written notice to the Corporation within five (5) business days of receipt of notice of such increase), shall be increased if such aggregate amount of Covered Securities sold in the Private Placement is
increased. In connection with its purchase of Designated Securities, such Holder shall, if it continues to wish to exercise its preemptive rights with respect to such offering, execute an agreement containing representations, warranties and
agreements of such Holder that are substantially similar in all material respects to the agreements executed by other purchasers in such Private Placement. 
 If, prior to consummation of a Qualified Offering, the terms of the proposed issuance change with the result that the price is less than the minimum price or more than the maximum price set 

 
forth in the notice contemplated by Section 7(b) or the other principal terms are more favorable in any material respect to the prospective
purchaser than those set forth in such notice, it shall be necessary for a separate notice to be furnished, and the terms and provisions of this Section 7 separately complied with. 
 Anything to the contrary in this Section 7 notwithstanding, the preemptive right to purchase Covered Securities granted by this
Section 7 as to a Holder shall terminate as of and not be available for any offering that commences at any time after the date on which such Holder offers, sells, pledges, or otherwise transfers any of the shares of Series A Preferred
Stock then held by such Holder, including by way of entry into any swap or other agreement or transaction that hedges or transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of such shares. In addition, the
preemptive rights granted hereunder shall only apply to the initial Holder of the Covered Securities. 
 B. Headings.

 The headings of the Sections of this Certificate are for convenience of reference only and shall not define, limit or affect any of the
provisions hereof. 
 [SIGNATURE PAGE FOLLOWS] 

 IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed in its name and on
its behalf on this      day of         , 2009. 
  

			
	THE COLONIAL BANCGROUP, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 Schedule 1 
 Purchasers 
 [SEE ATTACHED] 

 SCHEDULE 1 
 List of Purchasers 
 Allied Mortgage Group 
 AMA Advisors LLC 
 American Financial Resources,
Inc. 
 American Home Equity Corporation 
 AmeriFirst Financial Corporation 
 Atlantic Bay Mortgage Group 
 Coastal Mortgage Services, Inc. 
 Cornerstone Mortgage Co. 
 Cunningham and Company 
 D & L Prewitt Ltd
Partnership 
 Envoy Mortgage, Ltd. 
 Equity Services, Inc. 
 Scott Everett 
 Henry Fan 
 FBC Mortgage LLC 
 Franklin American Mortgage Company 
 James G. Hicks 
 Tibor Hollo 
 John B. Johnson 
 LendX Financial 
 Myers Park Mortgage, Inc. 
 Platinum Home Mortgage Corp. 
 Larry Pratt

 Provident Funding Associates, L.P. 
 Scott Bridge Company, Inc. 
 Securities Capital Holdings, Inc. 
 Security Atlantic Mortgage Co., Inc. 
 Pat Theodora Jr 
 Urban Financial Group, Inc. 
 WR Starkey
Mortgage 
 Gary Zwerling 
 Paul R.
Allen 
 Ray Bowman 
 Jeffery W.
Cavender 
 Jeremy Collett 
 Delton
de Armas 
 Sherry Dickinson 
 Taylor, Bean & Whitaker Mortgage Corp.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]